放射性视网膜病变中的血管功能障碍
放射性视网膜病变在接受眼外肿瘤放疗患者中发生率为6%,在接受眼部肿瘤放疗患者中超过40%。该综述总结了驱动放射性视网膜病变的序贯内皮和神经元改变,并讨论了可能指导治疗策略开发的分子和细胞通路。多模态成像尤其是光学相干断层扫描血管成像(OCTA)有助于早期检测。
要点
- 放射性视网膜病变在眼外肿瘤放疗患者中发生率为6%,眼部肿瘤放疗患者中超过40%
- OCTA等多模态成像可早期检测人类放射性视网膜病变
- 动物研究显示血管阻塞和稀疏以及早期神经血管功能障碍是临床期的核心特征
核心结论
- 放射性视网膜病变由序贯的内皮和神经元改变驱动,生物标志物和成像标志物可能有助于指导靶向干预。
研究设计与样本
- 综述,总结临床前和临床模型中放射性视网膜病变的分子和细胞机制证据。
主要发现
- 放射性视网膜病变在接受眼外肿瘤放疗患者中发生率为6%,在接受眼部肿瘤放疗患者中超过40%。
- 初始无症状阶段以血管重塑和慢性视网膜缺血为特征,之后可能进展为不可逆的视力丧失和生活质量显著受损。
- 动物研究强调血管阻塞和稀疏以及早期神经血管功能障碍是临床期的核心特征。
临床怎么用
- 除剂量约束等预防措施外,生物和成像标志物可能有助于指导靶向干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Optic tissue toxicity remains a major limitation of radiation therapy for ocular, brain, skull base, and head and neck tumors. Among the most frequent complications, radiation retinopathy (RR) occurs in 6% of patients treated for extraocular tumors and in more than 40% of those with ocular tumors. After an initial asymptomatic stage characterized by vascular remodeling and chronic retinal ischemia, RR may progress to irreversible vision loss and significantly impaired quality of life. Advances in non-invasive, high-resolution imaging have improved our understanding of the molecular and cellular mechanisms underlying RR in both preclinical and clinical models. In particular, multimodal imaging-and especially optical coherence tomography angiography (OCTA)-has enabled earlier detection of RR in humans. Animal studies have highlighted vascular obstruction and rarefaction, together with early neurovascular dysfunction, as central features of the clinical phase. Beyond preventive measures such as dose constraints, biological and imaging biomarkers may help guide targeted interventions. In this review, we summarize current evidence on the sequential endothelial and neuronal alterations that drive RR and discuss molecular and cellular pathways that could inform the development of potential therapeutic strategies.
引用
- Niaudet C, Mathis T, Pham TN, et al. Vascular dysfunctions during radiation retinopathy. Radiother Oncol. 2025. PMID: 41271176. doi:10.1016/j.radonc.2025.111294
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。